Quotient Clinical expands into USA through acquisition of SeaView…

Quotient Clinical , the early phase drug development services provider, today announces that it has acquired SeaView Research , expanding its operations into the USA. The acquisition combines Quotient and SeaView’s complementary customer portfolios, and strengthens the early phase clinical experience of the combined business, enabling the company to deliver a broader set of services.